Vered Behar

Vered Behar is the Co-Founder and Chief Executive Officer of Mylo Pharma, a pre-clinical biotech company focused on developing small molecule drugs for oncology and autoimmune diseases since March 2020. Behar is also a member of 8400 The Health Network (Cohort #6) as of November 2023. Previous roles include Vice President of R&D at MeMed Dx (July 2019 - January 2020), Chief Science Officer at Vidac Pharma (September 2012 - April 2019), and Vice President of R&D at Dynamix Pharmaceuticals (February 2009 - August 2012). Behar began a career in the biotech industry with roles such as Head of Biology at Third Rock Ventures and Chief Scientist at Quantomix. Educational qualifications include a PhD in Medical Sciences from Harvard Medical School, an MBA from The Hebrew University of Jerusalem, and participation in the Executive HealthTech program at Harvard Business School.